Company

Boston Scientific Corp BSX

Tracked across 9 disclosed holders on Protégé.

7 tracked investors, latest 13F quarter ending 30 Jun 2026 · 2 members of Congress · latest filing 25 Sep 2026

Held by these investors

All of 7 tracked investors by weight in their own portfolio. Source: each investor's latest SEC Form 13F-HR; quarter end and filing date per row.
InvestorWeight in portfolioValue (13F)Quarter endingFiled
Farallon Capital Management2.7%$449.0M2026-06-302026-08-14
Maverick Capital2.3%$253.4M2026-06-302026-08-14
D. E. Shaw & Co.0.7%$1.1B2026-06-302026-08-14
Two Sigma Investments0.6%$826.2M2026-06-302026-08-14
Voloridge Investment Management0.6%$139.8M2026-06-302026-08-14
Walleye Capital0.3%$67.4M2026-06-302026-08-03
Schonfeld Strategic Advisors0.3%$56.6M2026-06-302026-08-14

Members of Congress who disclosed trades

Disclosed trades by members of Congress. Net is buys minus sells at range midpoints. Source: STOCK Act periodic transaction reports; latest trade date per row.
PoliticianDisclosed activityEst. netLatest trade
Kevin Hern0 buys / 6 sells-$207K2026-09-09
Gilbert Cisneros7 buys / 1 sell$48K2026-08-18

Sources: SEC EDGAR (Form 13F-HR and Form 4) and the official House and Senate STOCK Act disclosures. Filings are quarterly or delayed, so current holdings may differ. Weights are each holder's own portfolio share, not a share of the company.

Open the companies explorer for BSX